skip navigation

Skip Nav

Education Materials

Education Materials
logo

National Women and Girls HIV/AIDS Awareness Day

March 10, 2017


According to the Centers for Disease Control and Prevention (CDC), approximately one in four people living with HIV in the United States are women. Between 2005 and 2014, the number of new HIV diagnoses among women declined 40%.
 
Not all women diagnosed with HIV, however, are getting the care that they need. CDC estimates that of all women diagnosed with HIV in 2013, 84% were linked to HIV medical care within 3 months, but only 55% of women living with HIV continued to receive HIV medical care. At the end of 2012, only 39% of women living with HIV were prescribed antiretroviral therapy (ART), and only 30% had achieved viral suppression

National Women and Girls HIV/AIDS Awareness Day is a nationwide event to promote HIV prevention, testing, and treatment to lessen the burden of HIV in women and girls. Browse the links on this page to learn more about this annual observance and to find HIV/AIDS-related information specific to women and girls.
logo

The U.S. Government Observes National Women and Girls HIV/AIDS Awareness Day

National Women and Girls HIV/AIDS Awareness Day Webpages:
logo

HIV/AIDS-Related Research and Women and Girls

FY 2017 Trans-NIH Plan for HIV-Related Research: Comprehensive plan for all National Institutes of Health (NIH) HIV-related research for 2017, from the Office of AIDS Research (OAR), NIH. The Plan describes NIH research priorities to prevent, treat, and eventually cure HIV/AIDS.

Clinical Trials Related to HIV/AIDS and Females: Research studies related to HIV/AIDS and women and girls, from the AIDSinfo clinical trial search. Call AIDSinfo at 1-800-448-0440 for assistance with your clinical trial search.

Research Related to HIV/AIDS and Women and Girls:
logo

Additional Information and Resources

Fact sheets, from AIDSinfo:
HIV and AIDS, from the Office on Women’s Health

HIV Among Women, from CDC

Women and HIV, from the Food and Drug Administration (FDA)

HIV/AIDS - Specific Populations: Women
Back to Top